ARCHIVES

ORI Finds Misconduct By Two Researchers

This article is from The Cancer Letter archive.

Vol. 21 No. 47 | December 8, 1995

Download PDF Visit The Full Archive

Related Articles

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

NCI Cooperative Group, Cancer Center Trials Listed

October 31, 2008

NCI to Fund 122 More Grants in FY04

March 28, 2003

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

May 18, 2007

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

April 22, 1994